All News

A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was confirmed by data from a new study.

Dr. Sheri Yolanda Prentiss discusses lymphedema as a result of cancer treatment and shares resources that exist for patients coping with this condition.

The FDA granted a positive review for an acute myeloid leukemia drug trial, with initial dosing expected in 2025.

The American Heart Association has released a statement detailing cardiometabolic considerations for survivors of childhood cancer.

Radiation therapy plays an important role in reducing the risk of cancer recurrence for patients with breast cancer undergoing breast reconstruction.

The FDA has approved Opdivo with Yervoy for patients 12 years old and older with MSI-H or dMMR colorectal cancer.

In an upside-down, topsy-turvy world, cancer can be a distraction for us.

SLS009 is associated with an improvement in survival among patients with relapsed/refractory acute myeloid leukemia.

Following a social media takeover with CURE, Sid Sadler sat down to talk about the topic of Kidney Cancer Awareness Month and patient advocacy.

It is important to recognize Kidney Cancer Awareness Month as a time to get involved, as more than 600,000 people in the U.S. live with kidney cancer.

Shorter radiation courses may improve breast reconstruction outcomes without increasing complications, according to Dr. Reshma Jagsi.

I always wanted to make a difference, but I never expected my biggest impact to come through cancer.

The BELLA phase 2 clinical trial of relacorilant plus nab-paclitaxel and Avastin among patients with platinum-resistant ovarian cancer has been launched.

Biomarkers can shape a breast cancer treatment plan, Andy Guinigundo explained in an interview with CURE.

Dr. Sheri Yolanda Prentiss explores the challenges patients face in accessing lymphedema compression garments following cancer treatment.

FDA grants orphan drug designation to HLX22 for gastric cancer, with a phase 2 trial showing improved progression-free survival and objective response.

Colorectal cancer is on the rise among younger adults, although potential explanations for the cause of this trend are likely years away.

PGV001, a personalized cancer vaccine, induced immune responses across various cancer types like breast and urothelial cancer, as well as multiple myeloma.

Bispecific antibodies target specific cells, offering effective treatment for relapsed/refractory multiple myeloma, with varying side effect profiles.

Dr. Valerie Lee discussed emerging targeted therapies and personalized medicine approaches that are showing promise for those with gastrointestinal cancer.

CAR-T therapy for myeloma faces challenges in early-line use due to accessibility, eligibility criteria and long wait times, despite strong efficacy in trials.

I tried using a Zen garden that helped me meditate and relax while dealing with the challenges of cancer, and it really works.

The FDA granted Breakthrough Therapy designation to IDE196 for the neoadjuvant treatment of primary uveal melanoma when enucleation has been recommended.

The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type of brain cancer.

Machine learning model improves transplant risk assessment for patients with myelofibrosis, helping clinicians make informed decisions, as per an expert.

Among patients with cancer, high out-of-pocket costs were found to impact access to health care, adherence to medication, as well as quality of life.

Although late-stage kidney cancer generated poor survival rates for over two decades, significant progress is being made in the treatment of the disease.

April is Head and Neck Cancer Awareness Month, and it is important to be aware of early signs and symptoms of the disease, as well as when to seek care.